Jing-wen Wang, M.D.
Beijing Tongren Hospital
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Rong Tao, MD & PhD
Shanghai Cancer Center
Shared therapeutic areas:
Udomsak Bunworasate, MD
Chulalongkorn University
Shared therapeutic areas:
Geoffrey Uy, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Hua Wang, MD
Sun Yat-senU
Shared therapeutic areas:
Shunan Qi, MD
Chinese Academy of Medical Sciences
Shared therapeutic areas:
Hua Wang
Sun Yat-sen University
Shared therapeutic areas:
Peng Liu, Ph.D
Fudan University
Shared therapeutic areas:
Qinzhou Qi
CStone Pharmaceuticals
Shared therapeutic areas:
Sairah Ahmed
MD Anderson
Shared therapeutic areas:
Seok-Goo Cho
The Catholic University of Korea
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma
Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma
All 2 trials loaded